Analysis of early results of edoxaban and warfarin in the treatment of deep vein thrombosis
Aim: Deep Vein Thrombosis (DVT) is an acute onset disease. Warfarin and new oral anticoagulants (NOAC) can be used for treatment. Edoxaban is one of the NOACs that acts directly as a ‘Factor Xa inhibitor'. The aim of our study was to investigate early treatment complications and efficacy in...
Saved in:
Main Authors: | Abdullah Guner, Volkan Burak Taban, Muhammet Talha Ceran, Yuksel Dereli |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkish National Vascular and Endovascular Surgery Society
2024-03-01
|
Series: | Turkish Journal of Vascular Surgery |
Subjects: | |
Online Access: | https://turkishjournalofvascularsurgery.org//?mno=199289 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deep vein thrombosis secondary to an ovarian tumor – approach in low resource settings: A case report
by: Korel Antonio Hernandez López, et al.
Published: (2024-03-01) -
Antiphospholipid Syndrome as a Cause of Recurrent Portal Vein Thrombosis in a Man with a Medical History of other Thrombosis
by: R. G. Sayfutdinov, et al.
Published: (2023-05-01) -
The Effect of Rosuvastatin on a murine model of deep vein thrombosis
by: Megan E. Barney, et al.
Published: (2025-03-01) -
Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
by: Takao Ohmori, et al.
Published: (2025-02-01) -
von Willebrand factor polymorphism (rs1063856) as a risk factor for portal vein thrombosis in chronic liver diseases
by: Isis Samy Bedira, et al.
Published: (2025-02-01)